Seeks to track the performance of a benchmark index that measures the investment return of stocks in the health care sector. Passively managed, using a Apr 19, 2006 The index is an equal weighted index and is rebalanced four times annually in March, June, September and December. Fund Overview. Ticker Oct 19, 2017 Key facts and comparisons for iShares Nasdaq US Biotechnology UCITS ETF ( BTEK | IE00BYXG2H39) ➤ justETF – The ETF Screener. The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily Factsheet EN KIID DE The fund replicates the performance of the underlying index by Fact Sheet as of 12/31/2019 The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. iShares Nasdaq Biotechnology ETF ($) The Hypothetical Growth of $10,000 chart reflects a hypothetical $10,000 investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted.
IBB tracks the performance of a market-cap-weighted index of biotechnology and iShares NASDAQ Biotechnology ETF has an MSCI ESG Fund Rating of BB
BTEC. iShares Nasdaq US Biotechnology UCITS. ETF. January Factsheet. Performance, Portfolio Breakdowns and Net Asset information as at: 31-Jan-. 2020. iShares NASDAQ-100® UCITS ETF (DE). January Factsheet The Fund seeks to track the performance of an index composed of 100 of the largest non- Get detailed information on iShares Nasdaq Biotechnology ETF including fund information, fund performance and ETF calculator on this ETF Factsheet. of the NASDAQ Biotechnology Index, which contains securities of companies listed on Seeks to track the performance of a benchmark index that measures the investment return of stocks in the health care sector. Passively managed, using a
iShares Nasdaq Biotechnology Index Fund (IBB) Historical ETF Quotes - Nasdaq offers historical quotes & market activity data for US and global markets.
Seeks to track the performance of a benchmark index that measures the investment return of stocks in the health care sector. Passively managed, using a Apr 19, 2006 The index is an equal weighted index and is rebalanced four times annually in March, June, September and December. Fund Overview. Ticker Oct 19, 2017 Key facts and comparisons for iShares Nasdaq US Biotechnology UCITS ETF ( BTEK | IE00BYXG2H39) ➤ justETF – The ETF Screener. The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily Factsheet EN KIID DE The fund replicates the performance of the underlying index by
Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.
Performance charts for iShares Nasdaq Biotechnology ETF (IBB - Type ETF) including that correspond to the performance of the Nasdaq Biotechnology Index. BTEC. iShares Nasdaq US Biotechnology UCITS. ETF. January Factsheet. Performance, Portfolio Breakdowns and Net Asset information as at: 31-Jan-. 2020.
iShares Nasdaq Biotechnology ETF Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.
Apr 19, 2006 The index is an equal weighted index and is rebalanced four times annually in March, June, September and December. Fund Overview. Ticker Oct 19, 2017 Key facts and comparisons for iShares Nasdaq US Biotechnology UCITS ETF ( BTEK | IE00BYXG2H39) ➤ justETF – The ETF Screener. The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily Factsheet EN KIID DE The fund replicates the performance of the underlying index by Fact Sheet as of 12/31/2019 The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. iShares Nasdaq Biotechnology ETF ($) The Hypothetical Growth of $10,000 chart reflects a hypothetical $10,000 investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted.